10th NTES Conference: Nickel and arsenic compounds alter the epigenome of peripheral blood mononuclear cells

Journal of Trace Elements in Medicine and Biology

Volumn 31, Issue , 2015, Pages 209-213

  Brocato, Jason ^a   Costa, Max ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Arsenic; Epigenetics; Histones modifications; Nickel; PBMCs

Indexed keywords

1 HISTONE H3 LYSINE 9; 2 HISTONE H3 LYSINE 9; 3 HISTONE H3 LYSINE 9; ARSENIC; CD14 ANTIGEN; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CXCR1; DEATH ASSOCIATED PROTEIN KINASE; DECTIN 1; DIOXYGENASE; DNA METHYLTRANSFERASE; HEME OXYGENASE 1; HISTONE ACETYLTRANSFERASE; HISTONE H3; HISTONE H3 LYSINE 9; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MAGNESIUM ION; NICKEL; TEN ELEVEN TRANSLOVATION PROTEIN; TOLL LIKE RECEPTOR 8; UNCLASSIFIED DRUG; HETEROCHROMATIN; HISTONE; ORGANOARSENIC DERIVATIVE;

ARTICLE; BLADDER CANCER; BLOOD TOXICITY; CARCINOGENICITY; CCL20 GENE; CCR2 GENE; CD14 GENE; CHROMATIN CONDENSATION; CLEC7A GENE; CX3CR1 GENE; CYTOTOXICITY; DAPK1 GENE; DNA METHYLATION; DOWN REGULATION; EPIGENETICS; EZH2 GENE; FCGR1B GENE; FGL2 GENE; FUCA1 GENE; GENE; GENE EXPRESSION; GENE REPRESSION; GENE SILENCING; GPT GENE; HETEROCHROMATINIZATION; HISTONE MODIFICATION; HMOX1 GENE; HUMAN; IGF6 GENE; IL1RN GENE; IL6 GENE; ILIA GENE; IMMUNOTOXICITY; IN VIVO STUDY; LIVER CANCER; LUNG CANCER; MGMT GENE; NONHUMAN; OCCUPATIONAL EXPOSURE; OXIDATIVE STRESS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SKIN CANCER; TLR8 GENE; UPREGULATION; ADVERSE EFFECTS; ARSENIC POISONING; DRUG EFFECTS; ENVIRONMENTAL EXPOSURE; GENETIC EPIGENESIS; GENETICS; HETEROCHROMATIN; METABOLISM; MONONUCLEAR CELL; PHYSIOLOGY;

ARSENIC POISONING; ARSENICALS; ENVIRONMENTAL EXPOSURE; EPIGENESIS, GENETIC; HETEROCHROMATIN; HISTONES; HUMANS; LEUKOCYTES, MONONUCLEAR; NICKEL;

EID: 84929653825     PISSN: 0946672X     EISSN: 18783252     Source Type: Journal    
DOI: 10.1016/j.jtemb.2014.04.001     Document Type: Article

References (50)

1. Arita A., Costa M. Epigenetics in metal carcinogenesis: nickel, arsenic, chromium and cadmium. Metallomics 2009, 1(3):222-228.
2. Brocato J., Costa M. Basic mechanics of DNA methylation and the unique landscape of the DNA methylome in metal-induced carcinogenesis. Crit Rev Toxicol 2013, 43(6):493-514.
3. Kurttio P., et al. Arsenic concentrations in well water and risk of bladder and kidney cancer in Finland. Environ Health Perspect 1999, 107(9):705-710.
4. Meliker J.R., Nriagu J.O. Arsenic in drinking water and bladder cancer: review of epidemiological evidence. Trace Metals Other Contaminants Environ 2007, (9):551-584.
5. Sorahan T., Williams S.P. Mortality of workers at a nickel carbonyl refinery, 1958-2000. Occup Environ Med 2005, 62(2):80-85.
6. Yuan T.H., et al. Possible association between nickel and chromium and oral cancer: a case-control study in central Taiwan. Sci Total Environ 2011, 409(6):1046-1052.
7. Chervona Y., Arita A., Costa M. Carcinogenic metals and the epigenome: understanding the effect of nickel, arsenic, and chromium. Metallomics 2012, 4(7):619-627.
8. Choudhuri S., Cui Y., Klaassen C.D. Molecular targets of epigenetic regulation and effectors of environmental influences. Toxicol Appl Pharmacol 2010, 245(3):378-393.
9. Zhou X., et al. Effects of nickel: chromate, and arsenite on histone 3 lysine methylation. Toxicol Appl Pharmacol 2009, 236(1):78-84.
10. Kargacin B., Klein C.B., Costa M. Mutagenic responses of nickel oxides and nickel sulfides in Chinese hamster V79 cell lines at the xanthine-guanine phosphoribosyl transferase locus. Mutat Res 1993, 300(1):63-72.
11. Cruz M.J., et al. Occupational asthma caused by chromium and nickel. Arch Bronconeumol 2006, 42(6):302-306.
12. Schmid M., et al. Influence of platinum: palladium and rhodium as compared with cadmium, nickel and chromium on cell viability and oxidative stress in human bronchial epithelial cells. Environ Int 2007, 33(3):385-390.
13. Salnikow K., et al. The involvement of hypoxia-inducible transcription factor-1-dependent pathway in nickel carcinogenesis. Cancer Res 2003, 63(13):3524-3530.
14. Hostynek J.J. Sensitization to nickel: etiology, epidemiology, immune reactions, prevention, and therapy. Rev Environ Health 2006, 21(4):253-280.
15. Salnikow K., Zhitkovich A. Genetic and epigenetic mechanisms in metal carcinogenesis and cocarcinogenesis: nickel, arsenic, and chromium. Chem Res Toxicol 2008, 21(1):28-44.
16. Costa M., et al. Nickel carcinogenesis: epigenetics and hypoxia signaling. Mutat Res 2005, 592(1-2):79-88.
17. Ouyang W., et al. Soluble and insoluble nickel compounds exert a differential inhibitory effect on cell growth through IKKalpha-dependent cyclin D1 down-regulation. J Cell Physiol 2009, 218(1):205-214.
18. Munoz A., Costa M. Elucidating the mechanisms of nickel compound uptake: a review of particulate and nano-nickel endocytosis and toxicity. Toxicol Appl Pharmacol 2012, 260(1):1-16.
19. Giri N.C., Passantino L., Sun H., Zoroddu M.A., Costa M., Maroney M.J. Structural investigations of the nickel-induced inhibition of truncated constructs of the JMJD2 family of histone demethylases using X-ray absorption spectroscopy. Biochemistry 2013, 52(24):4168-4183.
20. Ellen T.P., et al. Heterochromatinization as a potential mechanism of nickel-induced carcinogenesis. Biochemistry 2009, 48(21):4626-4632.
21. Chen H., et al. Nickel ions inhibit histone demethylase JMJD1A and DNA repair enzyme ABH2 by replacing the ferrous iron in the catalytic centers. J Biol Chem 2010, 285(10):7374-7383.
22. Chen H., et al. Hypoxia and nickel inhibit histone demethylase JMJD1A and repress Spry2 expression in human bronchial epithelial BEAS-2B cells. Carcinogenesis 2010, 31(12):2136-2144.
23. Chen H., et al. Nickel ions increase histone H3 lysine 9 dimethylation and induce transgene silencing. Mol Cell Biol 2006, 26(10):3728-3737.
24. Broday L., et al. Nickel compounds are novel inhibitors of histone H4 acetylation. Cancer Res 2000, 60(2):238-241.
25. Golebiowski F., Kasprzak K.S. Inhibition of core histones acetylation by carcinogenic nickel(II). Mol Cell Biochem 2005, 279(1-2):133-139.
26. Ke Q., et al. Alterations of histone modifications and transgene silencing by nickel chloride. Carcinogenesis 2006, 27(7):1481-1488.
27. Zoroddu M.A., et al. Interaction of Ni(II) and Cu(II) with a metal binding sequence of histone H4: AKRHRK, a model of the H4 tail. Biochim Biophys Acta 2000, 1475(2):163-168.
28. Kang J., et al. Nickel-induced histone hypoacetylation: the role of reactive oxygen species. Toxicol Sci 2003, 74(2):279-286.
29. Klein C.B., Costa M. DNA methylation, heterochromatin and epigenetic carcinogens. Mutat Res 1997, 386(2):163-180.
30. Lee Y.W., et al. Carcinogenic nickel silences gene expression by chromatin condensation and DNA methylation: a new model for epigenetic carcinogens. Mol Cell Biol 1995, 15(5):2547-2557.
31. Govindarajan B., et al. Reactive oxygen-induced carcinogenesis causes hypermethylation of p16(Ink4a) and activation of MAP kinase. Mol Med 2002, 8(1):1-8.
32. Zhang J., et al. Methylation of RAR-beta2: RASSF1A, and CDKN2A genes induced by nickel subsulfide and nickel-carcinogenesis in rats. Biomed Environ Sci 2011, 24(2):163-171.
33. Ji W., et al. Epigenetic silencing of O6-methylguanine DNA methyltransferase gene in NiS-transformed cells. Carcinogenesis 2008, 29(6):1267-1275.
34. Arita A., et al. Global levels of histone modifications in peripheral blood mononuclear cells of subjects with exposure to nickel. Environ Health Perspect 2012, 120(2):198-203.
35. Zhou X., et al. Hypoxia induces trimethylated H3 lysine 4 by inhibition of JARID1A demethylase. Cancer Res 2010, 70(10):4214-4221.
36. Arita A., Muñoz A., Chervona Y., Niu J., Qu Q., Zhao N., et al. Gene expression profiles in peripheral blood mononuclear cells of Chinese nickel refinery workers with high exposures to nickel and control subjects. Cancer Epidemiol Biomarkers Prev 2013, 22(2):261-269.
37. Dodd L.E., et al. Genes involved in DNA repair and nitrosamine metabolism and those located on chromosome 14q32 are dysregulated in nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev 2006, 15(11):2216-2225.
38. Torjussen W. Occupational nasal cancer caused by nickel and nickel compounds. Rhinology 1985, 23(2):101-105.
39. Jensen T.J., et al. Epigenetic remodeling during arsenical-induced malignant transformation. Carcinogenesis 2008, 29(8):1500-1508.
40. Tseng C.H., et al. Arsenic exposure: urinary arsenic speciation, and peripheral vascular disease in blackfoot disease-hyperendemic villages in Taiwan. Toxicol Appl Pharmacol 2005, 206(3):299-308.
41. Wasserman G.A., et al. Water arsenic exposure and children's intellectual function in Araihazar: Bangladesh. Environ Health Perspect 2004, 112(13):1329-1333.
42. Some drinking-water disinfectants and contaminants, including arsenic. IARC Monogr Eval Carcinog Risks Hum, 2004. 84: p. 1-477.
43. Schuhmacher-Wolz U., et al. Oral exposure to inorganic arsenic: evaluation of its carcinogenic and non-carcinogenic effects. Crit Rev Toxicol 2009, 39(4):271-298.
44. Kinniburgh D.G., Kosmus W. Arsenic contamination in groundwater: some analytical considerations. Talanta 2002, 58(1):165-180.
45. Leonardi G., et al. Inorganic arsenic and basal cell carcinoma in areas of Hungary, Romania, and Slovakia: a case-control study. Environ Health Perspect 2012, 120(5):721-726.
46. Chervona Y., Costa M. The control of histone methylation and gene expression by oxidative stress, hypoxia, and metals. Free Radic Biol Med 2012, 53(5):1041-1047.
47. Jensen T.J., et al. Epigenetic mediated transcriptional activation of WNT5A participates in arsenical-associated malignant transformation. Toxicol Appl Pharmacol 2009, 235(1):39-46.
48. Zhou X., et al. Arsenite alters global histone H3 methylation. Carcinogenesis 2008, 29(9):1831-1836.
49. Chervona Y., et al. Associations between arsenic exposure and global posttranslational histone modifications among adults in Bangladesh. Cancer Epidemiol Biomarkers Prev 2012, 21(12):2252-2260.
50. Bredfeldt T.G., et al. Xenoestrogen-induced regulation of EZH2 and histone methylation via estrogen receptor signaling to PI3K/AKT. Mol Endocrinol 2010, 24(5):993-1006.